Compared with the NC group, the level of the neuroinflammation-associated marker S100 calcium-binding protein β, but not glial fibrillary acidic protein (GFAP), was increased in the Braak stage V–VI AD group (Fig. 2j, Fig. S7). Here, S100B is linked to Alzheimer disease.